{
    "2019-05-29": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Pharmaceutical Stocks With Big Moats and Bridges",
                "features": {
                    "keywords": [
                        "pharmaceutical",
                        "stocks",
                        "moats",
                        "bridges"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "Lilly Announces Webcast to Discuss ADA Presentations and Diabetes Portfolio",
                "features": {
                    "keywords": [
                        "Lilly",
                        "webcast",
                        "ADA",
                        "diabetes",
                        "portfolio"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "Lilly In-Licenses Private Biotech's Non-Opoid Pain Candidate",
                "features": {
                    "keywords": [
                        "Lilly",
                        "in-licenses",
                        "biotech",
                        "non-opoid",
                        "pain"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "3 Big Stock Charts for Wednesday: Juniper Networks, Eli Lilly and Hormel Foods",
                "features": {
                    "keywords": [
                        "stock",
                        "charts",
                        "Juniper Networks",
                        "Eli Lilly",
                        "Hormel Foods"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "healthcare",
                        "consumer goods"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            },
            {
                "time": "2018-01-06",
                "original_text": "Pro-choice groups lost in Alabama despite outspending the pro-life side by 100-to-1",
                "features": {
                    "keywords": [
                        "pro-choice",
                        "Alabama",
                        "outspending",
                        "pro-life"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-07",
                "original_text": "Bayer to work with Foundation Medicine on selecting cancer patients",
                "features": {
                    "keywords": [
                        "Bayer",
                        "Foundation Medicine",
                        "cancer",
                        "patients"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}